(R) -CR8

• Description :

  (R) -CR8 is a potent and selective CDK inhibitor.A delayed systemic post-LFP administration at 3 hours of CR8--a potent second-generation cyclin-dependent kinase (CDK) inhibitor.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  431.53

• Molecular Formula :

  C24H29N7O

• Notes :

  Research use only, not for human use.

• Receptor :

  CDK

• CAS Number :

  294646-77-8